| # | Drug | Count |
|---|---|---|
| 0 | METOCLOPRAMIDE HYDROCHLORIDE | 2085 |
| 1 | METOCLOPRAMIDE | 2038 |
| 2 | PREDNISONE | 765 |
| 3 | OXYCODONE HYDROCHLORIDE | 569 |
| 4 | GABAPENTIN | 503 |
| 5 | ADALIMUMAB | 498 |
| 6 | SIMVASTATIN | 481 |
| 7 | METHOTREXATE SODIUM | 468 |
| 8 | ECULIZUMAB | 437 |
| 9 | METHOTREXATE | 436 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METOCLOPRAMIDE HYDROCHLORIDE | 2085 | 0.0268 |
| 1 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 40 | 0.0227 |
| 2 | DARUNAVIR ETHANOLATE AND COBICISTAT | 35 | 0.0199 |
| 3 | TESTOSTERONE CYPIONATE | 129 | 0.0143 |
| 4 | GADODIAMIDE | 37 | 0.0110 |
| 5 | GADOTERIDOL | 19 | 0.0105 |
| 6 | NELFINAVIR MESYLATE | 20 | 0.0096 |
| 7 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 59 | 0.0093 |
| 8 | TESTOSTERONE | 193 | 0.0081 |
| 9 | ECULIZUMAB | 437 | 0.0080 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1364 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1215 |
| 2 | Benzodiazepine [EPC] | 775 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 633 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 539 |
| 5 | Provitamin D2 Compound [EPC] | 513 |
| 6 | Proton Pump Inhibitor [EPC] | 460 |
| 7 | Complement Inhibitor [EPC] | 448 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 437 |
| 9 | Vitamin C [EPC] | 432 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 129 | 0.1875 |
| 1 | Provitamin D2 Compound [EPC] | 513 | 0.0172 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 19 | 0.0092 |
| 3 | Paramagnetic Contrast Agent [EPC] | 40 | 0.0087 |
| 4 | Complement Inhibitor [EPC] | 448 | 0.0080 |
| 5 | Lymphocyte Growth Factor [EPC] | 10 | 0.0079 |
| 6 | Androgen [EPC] | 202 | 0.0074 |
| 7 | Thymic Stromal Lymphopoietin Blocker [EPC] | 47 | 0.0068 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 103 | 0.0061 |
| 9 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 28 | 0.0047 |